Covid-19: Multiple companies working to develop vaccine for children

Studies of the vaccination trial test have been carried out at various places with an aim to soon start children vaccination

As the world gears up to fight the third wave, various medicine companies have already started vaccination trial on children of various age groups.
It was on October 7, when the Food and Drug Administration department was approached by Pfizer and BioNTech to authorize emergency vaccination on children from 5 to 11 years.
The members of the FDA's advisory committee are to meet on October 26 to further discuss this proposal.
The Pfizer's "BioNTrch vaccine has already been fully approved for people of 16 plus age and is available under an emergency use authorization for 12 to 15 years.
The Pfizer's "BioNTrch vaccine has already been fully approved for people of 16 plus age and is available under an emergency use authorization for 12 to 15 years.
Representational image.
Image: Representational image.
Studies have been carried out including 2268 children from the US and several other countries and a dose of 10 micrograms were pushed into them.
Thereafter the researchers carried out blood tests to check the levels of neutralizing antibody in their blood.
As per senior researchers, the reports of those samples were yet to be tested d and if it is found safe, then Pfizer and BioNTech might start their vaccination trials for the children of 5 to 11 years.



Be the first to start a discussion here. Sign-in to write a comment now!